leisure time -WSS

leisure time

author：leisure time 2025-09-28 23:44:41 - browse：795

Gene therapy helped Conner Curran, right, walk, but as the drug fades, his family is supporting scientific efforts to allow him and other boys get a second dose. -- Biotech coverage from STAT — Gene therapy helped Conner Curran (at right) walk, but as the drug fades, his family is supporting scientific efforts to allow him and other boys get a second dose. Courtesy Jess & Chris Curran

In the beginning, Conner Curran ran up the stairs.

It was a miraculous moment for him and his parents, Jess and Chris Curran. Just months before, contractors were in their New York home to install a motorized lift, while Jess tearfully explained that it wasn’t for a grandparent but for their 7-year-old son, who suffered from Duchenne muscular dystrophy and could barely haul himself up the steps.

Then Conner was accepted as the first patient in Pfizer’s Duchenne gene therapy trial. Three weeks later, he could bound to the second floor. Soon, he could walk the two-plus miles to Goldberg’s, a local bagel shop. “I couldn’t do that before,” he told NPR in 2020.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： What to watch for from Zogenix and Amicus clinical trials

WSS

What it's like to live with paralysis for one psychologist

U.K. officials, researchers try to ease path for bespoke genetic treatments

Why patients can’t get everything they want on drug pricing

Diabetes management: Digital health tools fall short, study says

Asbestos ban is immediate, but health effects will linger for decades

Biotech investment managers search for lucrative opportunities

explore

leisure time

knowledge

FDA approval of Sarepta Duchenne genetic therapy gives me hope

In the gardens at Boston Children's Hospital, families find sanctuary

United colonoscopy coverage change 'may cost lives,' doctors say

Adam's Take: Intra

Tori Bowie and the unacceptable rates of Black maternal death

Why patients can’t get everything they want on drug pricing

Walensky prepares to leave CDC — and Congress — behind

How doctors’ personal politics affect patients

Virginia high school admissions case could be legal follow

Mirador, a new biotech startup, launches with $400 million

hotspot

Senate panel puts off hardest PBM reforms for another day

'Investigate these claims': UFO transparency at center of House hearing

Senate panel puts off hardest PBM reforms for another day

A new crop of companies is reshaping the health data economy

New Alzheimer's drugs heat up race for early detection blood tests

Cancer, immunology, HIV research ensnared in fetal tissue politics

leisure time

hotspot

focus

hotspot